舒泰神：完成針對治療重型、危重型新型冠狀病毒肺炎適應(yīng)癥臨床試驗的首例健康受試者給藥

array(1) { [455053]=> array(2) { [2]=> array(4) { [0]=> string(12) "臨床試驗" [1]=> string(12) "冠狀病毒" [2]=> string(9) "舒泰神" [3]=> string(12) "肺炎疫情" } [4]=> array(1) { [0]=> string(19) "同花順7x24快訊" } } }